On Invalid Date, Protagenic Therapeutics (NASDAQ: PTIX) reported Q3 2023 earnings per share (EPS) of -$0.32, up 52.38% year over year. Total Protagenic Therapeutics earnings for the quarter were -$1.40 million. In the same quarter last year, Protagenic Therapeutics's earnings per share (EPS) was -$0.21.
As of Q1 2024, Protagenic Therapeutics's earnings has grown year over year. Protagenic Therapeutics's earnings in the past year totalled -$3.93 million.
What is PTIX's earnings date?
Protagenic Therapeutics's earnings date is Invalid Date. Add PTIX to your watchlist to be reminded of PTIX's next earnings announcement.
What was PTIX's revenue last quarter?
On Invalid Date, Protagenic Therapeutics (NASDAQ: PTIX) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Protagenic Therapeutics's revenue was $0.00.
What was PTIX's revenue growth in the past year?
As of Q1 2024, Protagenic Therapeutics's revenue has grown null year over year. Protagenic Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.